Cargando…
Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak
Glucocorticoids (GCs) represent an important component of modern treatment regimens for fludarabine-refractory or TP53-defective chronic lymphocytic leukemia (CLL). However, GC therapy is not effective in all patients. The molecular mechanisms responsible for GC-induced apoptosis and resistance were...
Autores principales: | Melarangi, T, Zhuang, J, Lin, K, Rockliffe, N, Bosanquet, A G, Oates, M, Slupsky, J R, Pettitt, A R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434667/ https://www.ncbi.nlm.nih.gov/pubmed/22898870 http://dx.doi.org/10.1038/cddis.2012.102 |
Ejemplares similares
-
Glucocorticoids can induce BIM to trigger apoptosis in the absence of BAX and BAK1
por: Dong, Li, et al.
Publicado: (2020) -
Bax/Bak activation in the absence of Bid, Bim, Puma, and p53
por: Zhang, J, et al.
Publicado: (2016) -
Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast Tumor
por: Miller, Anna V., et al.
Publicado: (2013) -
Combined loss of proapoptotic genes Bak or Bax with Bim synergizes to cause defects in hematopoiesis and in thymocyte apoptosis
por: Hutcheson, Jack, et al.
Publicado: (2005) -
The great migration of Bax and Bak
por: Edlich, Frank
Publicado: (2015)